Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure

Journal of Cardiac Failure
Naoki FujimotoMichiaki Hiroe

Abstract

This study investigates the predictive value of serum tenascin-C (TN-C), which is observed at the active sites of ongoing tissue remodeling, for cardiac events of patients with dilated cardiomyopathy (DCM). In this trial, 110 consecutive patients hospitalized with heart failure (HF) resulting from DCM underwent assessments of serum TN-C and plasma brain natriuretic peptide (BNP) levels at discharge and were followed up for 22.4 months. Cardiac function and hemodynamics were assessed invasively in 60 of these patients at discharge. There were 19 cardiac events (14 rehospitalizations, 3 deaths from refractory HF, and 2 sudden deaths) during follow-up. The average levels of TN-C and BNP were 73 +/- 38 ng/mL and 279 +/- 414 pg/mL, respectively. The optimal cutoff value for serum TN-C levels predicted cardiac events were >or=78.4 ng/mL, whereas BNP levels were >or=219 pg/mL. Patients with levels higher than this had significantly higher cardiac events and serum TN-C >or=78.4 ng/mL had an incremental predictive power with BNP for cardiac events. Left ventricular end-diastolic volume was significantly larger, and mean pulmonary arterial pressure was elevated in patients with serum TN-C >or=78.4 ng/mL. The combined index of serum level...Continue Reading

References

Dec 14, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·Peter Lloyd JonesJ William Gaynor
May 3, 2002·Journal of the American College of Cardiology·Nikolaos G FrangogiannisWilliam A Zoghbi
May 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jan Henrik HörstrupKai-Uwe Eckardt
Jul 13, 2002·The Journal of Pathology·Kyoko Imanaka-YoshidaToshimichi Yoshida
Feb 8, 2003·Circulation Research·Bernardo Nadal-GinardPiero Anversa
Apr 3, 2003·International Journal of Cancer. Journal International Du Cancer·Ilunga KalembeyiToshimichi Yoshida
Apr 20, 2004·The International Journal of Biochemistry & Cell Biology·Ruth Chiquet-Ehrismann, Richard P Tucker
Nov 30, 2004·The American Journal of Cardiology·Nobuko AsoMasaru Nasu
Feb 3, 2005·The Journal of Pathology·Shin-Ichiro MorimotoMichiaki Hiroe
Apr 25, 2006·Cancer Letters·Gertraud Orend, Ruth Chiquet-Ehrismann
Jun 6, 2006·Journal of the American College of Cardiology·Akira SatoMichiaki Hiroe
Jun 9, 2006·The New England Journal of Medicine·Lesley A StevensAndrew S Levey
Jun 20, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kaori Ihida-StansburyPeter Lloyd Jones
Aug 29, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Gregory L BrowerJoseph S Janicki
Feb 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Fumio TerasakiUNKNOWN Study Group for Intractable Diseases by a Grant from the Ministry of Health, Labor and Welfare of Japan
Jul 17, 2007·Circulation·W H Wilson TangUNKNOWN National Academy of Clinical Biochemistry Laboratory Medicine
Mar 31, 2009·European Journal of Heart Failure·Michele EmdinAldo Clerico

❮ Previous
Next ❯

Citations

Aug 6, 2011·Cellular and Molecular Life Sciences : CMLS·Kim S MidwoodGertraud Orend
Jun 30, 2011·Cardiovascular Research·Jonathan GolledgeSimon Koblar
Sep 29, 2011·Pathology International·Taizo KimuraMasunori Matsuzaki
Sep 17, 2014·Biomarkers in Medicine·Jonathan R DalzellRoy S Gardner
Sep 17, 2014·Biomarkers in Medicine·Joanne SimpsonRoy S Gardner
Feb 18, 2016·European Journal of Internal Medicine·Yuichiro MinamiUNKNOWN ATTEND Study Investigators
Nov 28, 2012·Heart, Lung & Circulation·Heng-Chen YaoLe-Xin Wang
May 29, 2012·Journal of Cardiac Failure·Akira SatoKazutaka Aonuma
Jul 31, 2010·Life Sciences·Claude Jourdan-LesauxMerry L Lindsey
Sep 24, 2015·Life Sciences·Sukru UlusoyDiler Us Altay
Sep 3, 2011·Cardiovascular Therapeutics·Hiroshi Okamoto, Kyoko Imanaka-Yoshida
Jun 8, 2013·International Journal of Cardiology·Toshihiro NozatoMichiaki Hiroe
May 21, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Irena Niebroj-DoboszIrena Hausmanowa-Petrusewicz
Jun 13, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Irena Niebroj-Dobosz
Nov 8, 2014·Journal of the American Heart Association·Tomoko Machino-OhtsukaKyoko Imanaka-Yoshida
Apr 27, 2012·Physiological Reviews·Nikolaos G Frangogiannis
Nov 7, 2019·Pathology International·Kyoko Imanaka-Yoshida
Aug 18, 2020·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Prathap KanagalaLeong L Ng
Jun 25, 2015·Expert Review of Cardiovascular Therapy·Caroline J CoatsPerry M Elliott
Jan 19, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Tomohiro NishiokaKyoko Imanaka-Yoshida
Aug 28, 2020·American Journal of Physiology. Cell Physiology·Kyoko Imanaka-YoshidaToshimichi Yoshida
Sep 23, 2020·Current Problems in Cardiology·Eduardo BossoneArturo Evangelista
Dec 19, 2020·Frontiers in Immunology·Ken-Ichi Matsumoto, Hiroki Aoki
Mar 12, 2021·Frontiers in Immunology·Kazuko TajiriMasaki Ieda
Jun 18, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Junichi TakiSeigo Kinuya
Jun 3, 2021·International Journal of Molecular Sciences·Kyoko Imanaka-Yoshida
Aug 1, 2021·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Nicoline W E van den BergUNKNOWN PREDICT-AF Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.